Essential medicines pricing—reform needed
- 1 January 2009
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 373 (9659) , 191-193
- https://doi.org/10.1016/s0140-6736(08)61763-8
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- The burden and costs of chronic diseases in low-income and middle-income countriesThe Lancet, 2007
- The availability and affordability of selected essential medicines for chronicl diseases in six low- and middle-income countriesPublished by WHO Press ,2007
- The pricing and procurement of antiretroviral drugs: an observational study of data from the Global FundPublished by WHO Press ,2006
- ARV prices nosedive after Clinton brokeringThe Lancet, 2003
- Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adultsPublished by Elsevier ,2003
- Increasing transparency in partnerships for health – introducing the Green Light CommitteeTropical Medicine & International Health, 2002
- Ten recommendations to improve use of medicines in developing countriesHealth Policy and Planning, 2001